HTFL (HeartFlow) Total Stockholders Equity: $279.7 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

HTFL HeartFlow Inc HTFL
12 GF Score
Price $48.49
! 6 Warning Signs
View Full Analysis

What is HeartFlow Total Stockholders Equity?

HeartFlow HTFL -1.90% 12 Total Stockholders Equity is $279.7 Mil as of Jun. 2026. GuruFocus rates HTFL with a GF Score™ of 12/100. The stock has 6 warning signs investors should review.

HeartFlow's Total Stockholders Equity for the quarter that ended in Jun. 2026 was $279.7 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. HeartFlow's Book Value per Share for the quarter that ended in Jun. 2026 was $3.23. The ratio of a company's debt over equity can be used to measure how leveraged this company is. HeartFlow's Debt-to-Equity for the quarter that ended in Jun. 2026 was 0.10.


HeartFlow  (NAS:HTFL) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

HeartFlow's Book Value per Share for the quarter that ended in Jun. 2026 is

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

HeartFlow's Debt-to-Equity for the quarter that ended in Jun. 2026 is

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


HeartFlow Total Stockholders Equity Related Terms


HeartFlow Total Stockholders Equity Historical Data

* Premium members only.

The historical data trend for HeartFlow's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

HeartFlow Total Stockholders Equity Chart

HeartFlow Annual Data
Trend Dec23 Dec24 Dec25
Total Stockholders Equity
-777.56 -859.48 300.65

HeartFlow Quarterly Data
Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Total Stockholders Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only -894.80 254.57 300.65 285.72 279.73
HTFL
12GF Score
HeartFlow Inc HTFL
Total Stockholders Equity is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
What does a Total Stockholders Equity of $279.7 Mil mean?
HeartFlow (HTFL) has a Total Stockholders Equity of $279.7 Mil as of Jun. 2026. The total amount of shareholder's equity as recorded on a company's balance sheet. View historical data for HeartFlow and its competitors.
Is HeartFlow's Total Stockholders Equity too high?
HeartFlow's current Total Stockholders Equity is $279.7 Mil. Overall, HeartFlow has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does HeartFlow's Total Stockholders Equity compare to OMCL and TDOC?
HeartFlow's Total Stockholders Equity of $279.7 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Stockholders Equity for a Healthcare Providers & Services company?
A good Total Stockholders Equity depends on the Healthcare Providers & Services industry context. However, Total Stockholders Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Stockholders Equity mean?
A high Total Stockholders Equity can signal that a stock is expensive relative to its fundamentals. The total amount of shareholder's equity as recorded on a company's balance sheet. View historical data for HeartFlow and its competitors. HeartFlow's current Total Stockholders Equity is $279.7 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is HeartFlow stock overvalued right now?
HeartFlow (HTFL) has a current Total Stockholders Equity of $279.7 Mil. The current Total Stockholders Equity is $279.7 Mil. HeartFlow's overall GF Score™ is 12/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Stockholders Equity calculated?
Total Stockholders Equity is calculated from a company's financial statements. For HeartFlow (HTFL), the current Total Stockholders Equity is $279.7 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

HeartFlow Business Description

Address 331 East Evelyn Avenue, Mountain View, CA, USA, 94041
HeartFlow Inc is a commercial-stage medical technology company that provides software and artificial intelligence (AI) designed to deliver a non-invasive solution for diagnosing and managing coronary artery disease. The company operates and manages its business as a single reportable operating segment: non-invasive coronary artery disease detection solutions. Geographically, it operates in the United States and the rest of Europe, deriving the majority of its revenue from the United States. The company has developed three software products: Heartflow Roadmap Analysis, Heartflow FFRCT Analysis, and Heartflow Plaque Analysis.
12GF Score

Get the complete analysis for HTFL

Total Stockholders Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$48.49
Price